The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Methamphetamine (METH) is closely related chemically to amphetamine (AMPH). METH is a potent central nervous system stimulant with additional peripheral sympathomimetic effects. METH and AMPH have been used clinically in the treatment of obesity, minimal brain dysfunction, narcolepsy, depression and to counter fatigue. They are also subjected to widespread abuse. METH is an indirect agonists. It causes the release of newly synthesized norepinephrine and dopamine and it blocks the re uptake of these transmitters from the synapse. This can lead to an increase in the concentration of catecholamines in the synapse as well as an overall increase in catecholaminergic activity in the brain. The mechanism of METH induced neurotoxicity for all monoaminergic cell types may lie primarily with the dopaminergic system in the striatum. It may also lie with the interaction between METH induced release of dopamine and its ability to inhibit monoamine oxidase.
Anti-Methamphetamine antibody [4E2] images
ELISA - Methamphetamine antibody [4E2] (ab23328)
A competitive ELISA was performed using various drugs at a concentration of 10 ng/ml. Only methamphetamine was able to block the binding of the antibody to the antigen.
References for Anti-Methamphetamine antibody [4E2] (ab23328)
has not yet been referenced specifically in any publications.
Publishing research using ab23328? Please let us know so that we can cite the reference in this datasheet.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up